Publication:
Treatment of Masseteric Hypertrophy with Botulinum Toxin: A Report of Two Cases

dc.authorscopusid20733782300
dc.authorscopusid36086601600
dc.authorscopusid23470335700
dc.authorscopusid56248493700
dc.contributor.authorBaş, B.
dc.contributor.authorÖzan, B.
dc.contributor.authorMug̈lali, M.
dc.contributor.authorÇelebi, N.
dc.date.accessioned2020-06-21T14:47:51Z
dc.date.available2020-06-21T14:47:51Z
dc.date.issued2010
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Baş] Burcu, Department of Oral and Maxillofacial Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özan] Bora, Department of Oral and Maxillofacial Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Mug̈lali] Mehtap, Department of Oral and Maxillofacial Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Çelebi] Nükhet, Department of Oral and Maxillofacial Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractMasseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek. Several treatment options reported for masseter hypertrophy, which range from simple pharmacotherapy to more invasive surgical reduction. Botulinum toxin type A is a powerful neurotoxin which is produced by the anaerobic organism Clostridium botulinum and when injected into a muscle causes interference with the neurotransmitter mechanism producing selective paralysis and subsequent atrophy of the muscle. Injection of botulinum toxin type A into the masseter muscle is generally considered a less invasive modality and has been advocated for cosmetic sculpting of the lower face. Botulinum toxin type A injection is considered to be a beneficial treatment modality in masseter muscle hypertrophy patients. The aim of this article is to report two cases of masseteric muscle hypertrophy which were treated with botulinum toxin type A injection. Marked changes in facial feature were achieved 3 months after the procedure. © Medicina Oral S. L.en_US
dc.identifier.doi10.4317/medoral.15.e649
dc.identifier.endpagee652en_US
dc.identifier.issn1698-4447
dc.identifier.issn1698-6946
dc.identifier.issue4en_US
dc.identifier.pmid20173718
dc.identifier.scopus2-s2.0-77954609818
dc.identifier.scopusqualityQ1
dc.identifier.startpagee649en_US
dc.identifier.urihttps://doi.org/10.4317/medoral.15.e649
dc.identifier.volume15en_US
dc.identifier.wosWOS:000279667400021
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherMedicina Oral S Len_US
dc.relation.ispartofMedicina Oral, Patología Oral y Cirugía Bucalen_US
dc.relation.journalMedicina Oral Patologia Oral Y Cirugia Bucalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBotulinum Toxin Type Aen_US
dc.subjectHypertrophyen_US
dc.subjectMasseter Muscleen_US
dc.titleTreatment of Masseteric Hypertrophy with Botulinum Toxin: A Report of Two Casesen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files